Editorial Comment to Intermittent everolimus administration for renal angiomyolipoma associated with tuberous sclerosis complex

Int J Urol. 2017 Nov;24(11):785-786. doi: 10.1111/iju.13437. Epub 2017 Sep 14.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Angiomyolipoma*
  • Antineoplastic Agents*
  • Everolimus
  • Humans
  • Kidney Neoplasms*
  • Tuberous Sclerosis*

Substances

  • Antineoplastic Agents
  • Everolimus